| Date | Title | Description |
| 16.09.2026 | Cedar Gate Survey Reveals 83% of Health Plans Miss VBC Outcomes Due to Fragmented Data | What You Should Know
A national research study conducted by Wakefield Research for Cedar Gate Technologies (an IQVIA business) surveyed 100 senior U.S. health plan executives (VP level and above) across actuarial science, clinical operation... |
| 08.09.2026 | Nestlé USA launches kids hydration drink Gerberlyte | Listen to the article 4 min
This audio is auto-generated. Please let us know if you have feedback.
Nestlé USA is bringing Gerber into the pediatric rehydration space as the CPG giant expands the infant and toddler brand beyond its core meal... |
| 03.09.2026 | HEOR Services Market to Reach $7.9 Billion as Payers Demand Stronger Evidence on Treatment Value | Rockville, Maryland, United States – September 3, 2026 — The U.S. Centers for Medicare & Medicaid Services selected 15 high-cost Medicare Part B and Part D drugs for the third cycle of Medicare drug price negotiations in January 2026, b... |
| 17.08.2026 | GDPR fines surge by 230% in Q2 2026 despite strict regulations |
Eight years after Europe introduced one of the world’s toughest data protection regimes, the financial cost of falling foul of it is still climbing.
Since the General Data Protection Regulation (GDPR), came into force in 2018, Europe’s dat... |
| 15.08.2026 | Global AI Awards 2026 Season 2 Announces Winners Across Pivotal Artificial Intelligence Categories | The Global AI Awards proudly concludes its 2026 Season 2 program, celebrating groundbreaking advancements and transformative achievements that continue to elevate the global AI landscape.
AUSTIN, Texas, Aug. 15, 2026 /PRNewswire-PRWeb/ -- T... |
| 12.08.2026 | Virtual Clinical Trials Market Expected to Reach USD 13.56 Billion by 2031 as Decentralized Research and Cloud-Based Platforms Gain Ground | Virtual Clinical Trials Market Overview
According to Mordor Intelligence, the Virtual Clinical Trials Market Size is estimated at USD 10.32 billion in 2026 and is projected to reach USD 13.56 billion by 2031, registering a CAGR of 5.62% dur... |
| 21.07.2026 | Simon-Kucher appoints Falko Graf-Meisner as Partner in its Healthcare & Life Sciences division | Simon-Kucher appoints Falko Graf-Meisner as Partner in its Healthcare & Life Sciences division
Tue, Jul 21, 2026 15:03 CET Report this content
Frankfurt, 21 July 2026 – Simon-Kucher, the world's leading commercial growth and pricing con... |
| 20.07.2026 | What to know about testosterone replacement therapy as the U.S. military plans to test troops | Testosterone replacement therapy is back in the spotlight after the U.S. military said it will begin testing service members’ testosterone levels and make replacement therapy available to those who qualify.
The therapy is a synthetic form o... |
| 08.07.2026 | Moderna Appoints Michael McDonnell to Board of Directors | Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience
CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the appointment of Michael Mc... |
| 06.07.2026 | Global NLP in Healthcare and Life Sciences Market (By Application intensity, Deployment architecture, End Use, Region), Key Company Profiles, Market Dynamics and Recent Developments – Forecast to 2032... | The global NLP in healthcare and life sciences market was valued at USD 4.8 billion in 2025 and is projected to reach USD 23.3 billion by 2032, expanding at a CAGR of around 25.3% during the forecast period, according to the provided report... |
| 30.06.2026 | EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026 | SAN DIEGO, June 30, 2026 /PRNewswire/ -- At BIO 2026, EirGenix presented its comprehensive HER2-positive breast cancer biosimilar portfolio and highlighted its integrated one-stop contract development and manufacturing organization (CDMO) s... |
| 14.06.2026 | Kos Biotechnology Partners Announces Third Fund Closing At $123 Million | Kos Biotechnology Partners, a global life sciences investment firm focused on connecting the U.S. biopharma ecosystem with Europe, announced the third closing of its inaugural global life sciences fund, bringing total capital commitments to... |
| 11.06.2026 | ByteDance spins out drug discovery unit to test AI4S commercialization | ByteDance’s artificial intelligence drug discovery unit has begun the process of spinning off and raising independent financing, according to people familiar with the matter.
ByteDance will retain a controlling stake in the new company afte... |
| 18.05.2026 | Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pill | Novo Nordisk sees a “major opportunity” outside of the U.S. and says that telehealth partners could help grow the global market for weight loss drugs.
The battle for dominance over the lucrative market has so far focused largely on the key ... |
| 15.05.2026 | EUR 2.1M for Graftcode to Eliminate Traditional Integration Complexity | Warsaw-based developer platform Graftcode raised EUR 2.1M Seed funding led by Hard2Beat The startup’s founders previously built Javonet, enabling cross-platform runtime bridging for enterprises The new platform uses runtime bridging to remo... |
| 07.05.2026 | XRHealth Named Winner of the 2026 MedTech Breakthrough Telehealth Innovation Award | XRHealth has been named winner of the 2026 MedTech Breakthrough "Telehealth Innovation Award," selected from more than 5,000 global nominations alongside industry leaders including Noom, Teladoc, and Medtronic. The recognition hig... |
| 29.04.2026 | European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe | SHANGHAI, April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for... |
| 29.04.2026 | Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 | MUMBAI, India, April 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarte... |
| 28.04.2026 | Nuevocor Appoints Dr. Monica Shah as Chief Medical Officer | SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening cardiomyopathies, today announced the appointment of ... |
| 31.03.2026 | Stephen Corba Addresses Clinical Research, Comparator Sourcing, and Drug Cost Reduction | Stephen Corba MONMOUTH COUNTY, NJ, UNITED STATES, March 30, 2026 /EINPresswire.com/ -- Stephen Corba, a healthcare logistics and clinical research infrastructure professional with more than 20 years of experience, today issued a statement a... |
| 26.03.2026 | Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA | Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the past 10 years. IQVIA shared the data in a report that tracked surges in the number of deals with Chinese biotechs ... |
| 20.03.2026 | QHP Capital: $1.1 Billion Continuation Vehicle Raised For Azurity Pharmaceuticals | QHP Capital has closed a $1.1 billion single-asset continuation vehicle to support its portfolio company Azurity Pharmaceuticals, providing liquidity to existing investors while positioning the business for continued long-term growth.
The t... |
| 16.03.2026 | Nvidia launches enterprise AI agent platform with Adobe, Salesforce, SAP among 17 adopters at GTC 2026 | Jensen Huang walked onto the GTC stage Monday wearing his trademark leather jacket and carrying, as it turned out, the blueprints for a new kind of monopoly.
The Nvidia CEO unveiled the Agent Toolkit, an open-source platform for building au... |
| 07.03.2026 | Should drug companies be advertising to consumers? | Getting your Trinity Audio player ready...
By Paula Span, KFF Health News
Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arli... |
| 17.02.2026 | Moberg Pharma Year-end report 2025 | Moberg Pharma Year-end report 2025
Tue, Feb 17, 2026 08:00 CET Report this content
A BREAKTHROUGH YEAR WITH A CLEAR PATH TO EUROPE
THE YEAR (JAN-DEC 2025) Net revenue SEK 13.5 million (9.8) EBITDA SEK -25.7 million (-23.5) Operating profit ... |
| 10.02.2026 | Basketball Superstar Kevin Durant Becomes the "New Face of Legs" in CeraVe's Latest "Moisturise Like a Derm" Campaign | The Social-First Edutainment Campaign Champions Total Body Skin Health, Emphasising CeraVe's Solutions to Common Skin Issues
NEW YORK, Feb. 10, 2026 /PRNewswire/ -- CeraVe, the #1 recommended moisturiser brand by dermatologists worldwide, t... |
| 05.02.2026 | IQVIA backs AI strategy as analysts question impact on business | Feb 5 : Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst concerns that recent technology advances could displace the company's services, after it forecast annual profit below... |
| 29.01.2026 | uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025 | Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f... |
| 27.01.2026 | Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030 | Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24.
Growth over the financial year was driven by increased sales in oncology, particularly in the United States.
Several partnership agreements in oncology and ... |
| 16.01.2026 | Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch | Shares of Novo Nordisk rose more than 8% on Friday after early prescription data showed an encouraging start to the launch of the company’s new GLP-1 pill for obesity in the U.S.
In a Friday note, TD Cowen analysts called it a “solid start”... |
| 15.01.2026 | How Agentic AI is Reclaiming 40% of Pharmacovigilance Capacity | Deepanshu Saini, Director of Program Management at IQVIA
Pharmaceutical companies are tasked with managing vast volumes of patient data, product information and safety reports. Yet, much of this valuable intelligence remains buried in trans... |
| 30.12.2025 | AI in Pharmacovigilance: Balancing Innovation with Regulatory Trust in 2026 | Ana Pedro Jesuíno, Marketed Product Safety Associate Director, IQVIA
Pharmacovigilance (PV) is experiencing a renaissance. Artificial Intelligence (AI) is no longer a futuristic concept in PV; it’s here, reshaping how we manage safety data,... |
| 29.12.2025 | Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy | TAIPEI and SAN DIEGO, Dec. 29, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging... |
| 16.12.2025 | 2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over | If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from “flashy, one-off experiments” to “top-down programs designed for measurable impact”. Across the digi... |
| 15.12.2025 | uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials | On behalf of the Critical Path Institute (C-Path) Florence Mowlem PhD, led this much-needed project, providing 10 best practices for EDeD design and implementation to support clinical trial data capture, along with co-authors from Top 10 ph... |
| 12.12.2025 | A pair of CEO transitions and more leadership moves across the market | Scout Space
Josiah Gruber has been promoted to CEO at this specialist in observation data and other vision solutions, where he worked as chief technology officer for the past year.
Gruber first joined Scout Space in 2023 as an engineer befo... |
| 10.12.2025 | MALAYSIA UNVEILS FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL AWARD WINNER TO DRIVE GLOBAL ECONOMY COMPETITIVENESS | KUALA LUMPUR, Malaysia, Dec. 10, 2025 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH... |
| 09.12.2025 | ISLAND HOSPITAL NAMED MALAYSIA'S FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL | GEORGETOWN, Malaysia, Dec. 9, 2025 /PRNewswire/ -- Island Hospital is the winner of Malaysia's first Flagship Medical Tourism Hospital (FMTH) programme, a recognition of its consistent standards in care, safety and patient experience for in... |
| 03.12.2025 | How Platform Engineers Transform Pharmaceutical Compliance from Burden to Business Advantage | Share
Share
Share
Share
Email
Nivedha Sampath’s nine-year journey from large-scale patient data migrations to leading global compliance infrastructure modernization in the pharmaceutical industry
More than 25% of FDA warning letters since 2... |
| 11.11.2025 | Moberg Pharma interim report January - September 2025 | Moberg Pharma interim report January - September 2025
Tue, Nov 11, 2025 08:00 CET Report this content
FURTHER SUCCESS FOR TERCLARA
NINE-MONTH PERIOD (JAN-SEP 2025) Net revenue SEK 11.5 million (8.8) EBITDA SEK -18.7 million (-15.7) Operatin... |
| 28.10.2025 | CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved Patients on World Skin Health Day | In Partnership with the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD), CeraVe Mobilizes 9 Countries to Expand Access to Dermatological Care Worldwide
NEW YORK, Oct. 28, 2025 /PRNe... |
| 22.10.2025 | Pharmaceutical, life science industries drive trade surge between Indiana and Portugal | Please subscribe to IBJ to decode this article.
oceaseeaaan varlteeaeenaselm f eeva.gylo tih ecucorc id srli fts ht aamTgduotfd np ioe hciin’aes wusodyeir epnlnitte r,aIih rprsssttdyinn eltt rheeogPepdftt
aaAsao orh edyi atdo.cias rhdefrc n... |
| 15.10.2025 | Cereno Scientific to Participate at BIO-Europe Fall 2025 in Vienna – the Global BioPharma Partnering Event | Cereno Scientific to Participate at BIO-Europe Fall 2025 in Vienna – the Global BioPharma Partnering Event
Wed, Oct 15, 2025 07:45 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering trea... |
| 08.10.2025 | Rwanda: Digital Health for Community Impact - Beyond Access to Real Transformation | The internet, computers, and smartphones have changed our lives forever and these technologies have not left the healthcare industry untouched. The Covid-19 pandemic accelerated this change and the adoption of digital health technologies. H... |
| 08.10.2025 | Adora AI Platform Doubles Return on Ad Spend for Fortune 500 Brands | At Advertising Week New York, Adora today launched its end-to-end AI performance marketing engine, enabling Fortune 500 brands to activate revenue-driving campaigns in hours instead of weeks—addressing the fundamental speed crisis that has ... |
| 03.10.2025 | IQM Named Best Demand Side Technology at the 2025 AdExchanger Awards | IQM Advertising Corporation, the global media buying platform empowering advertisers in the most regulated verticals to use and enhance their data to make better ad buying decisions, is proud to announce that it has been named Best Demand S... |
| 30.09.2025 | Novartis Singapore and the Singapore Heart Foundation Launch 'Beat the Block' Campaign to Raise Awareness of High Blood Cholesterol | Local survey reveals critical misconceptions and gaps in blood cholesterol management among people living in Singapore.
Almost one in three deaths in Singapore is attributed to cardiovascular disease, underscoring the urgent need to improve... |
| 19.09.2025 | European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively | SHANGHAI and JERSEY CITY, N.J., Sept. 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for BILDYOS® (denosumab) injec... |
| 10.09.2025 | BioGaia AB establishes its own distribution in Germany and Austria | BioGaia AB establishes its own distribution in Germany and Austria
Wed, Sep 10, 2025 16:00 CET Report this content
BioGaia AB (NASDAQ: BIOG) establishes its own distribution in Germany and Austria through a newly formed subsidiary in German... |
| 07.09.2025 | 🔥 Quick Fire with Ayodeji Alaran | Ayodeji Alaran is the founder and CEO of PBR Life Sciences, a healthtech company working to fix Africa’s healthcare data problem. After years of seeing drug oversupply, expiry, and waste across the continent, he launched PBR to help pharmac... |
| 02.09.2025 | US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively | SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg... |
| 12.08.2025 | For everyone with sensitive skin: Understanding skin science with Cetaphil and its new innovative product | KUALA LUMPUR, Malaysia, Aug. 12, 2025 /PRNewswire/ -- Cetaphil®, the trusted global leader in sensitive skincare and the No. 1 dermatological skincare brand in Malaysia*, announced a transformative rebrand with a bold shift towards an advoc... |
| 07.08.2025 | Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ) | Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ)
Thu, Aug 07, 2025 07:00 CET Report this content
Lund, Sweden August 7, 2025, Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in... |
| 06.08.2025 | B2B eCommerce Surges with AI, Study Shows Industry Gains | Lucidworks, the leading AI-powered search and product discovery provider, today released new B2B-focused findings from its third annual Generative AI Global Benchmark Study, a comprehensive report of 1,600+ AI leaders and 1,100+ company web... |
| 23.07.2025 | CeraVe Celebrates Two Decades of "Developed with Dermatologists" Skincare: A 20th Birthday Tribute to Skin Barrier Science and Innovations | A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare Brand
NEW YORK, July 23, 2025 /PRNewswire/ -- It's CeraVe-time to celebrate! CeraVe, the global skincare brand ... |
| 22.07.2025 | Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific | SINGAPORE, July 22, 2025 /PRNewswire/ -- The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass of innovative therapies that will redefine treatment, attract investment and improve lives, a new e... |
| 22.07.2025 | Dow futures pop more than 200 points after Trump announces Japan trade deal: Live updates | Stock futures rose Wednesday after President Donald Trump announced the U.S. had reached a trade deal with Japan, lifting hope for further agreements being made.
Futures linked to the Dow Jones Industrial Average traded 217 points higher, o... |
| 18.07.2025 | Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025 | Image Credit: HGP July 2025 Health IT Market Review
What You Should Know:
– The first half of 2025 presented a volatile backdrop of policy shocks and economic uncertainty, yet the Health IT sector demonstrated remarkable resilience, seeing ... |
| 02.07.2025 | KLAS Report: State of EHR Adoption in Asia & Oceania in 2025 | Image Credit: KLAS Asia/Ocenia EHR 2025
What You Should Know:
– The healthcare technology landscape in Asia and Oceania is experiencing significant growth, driven by increasing digital maturity and a strong desire for enhanced interoperabil... |
| 01.07.2025 | LogicFlo: The AI Revolutionizing Life Sciences Workflows | In the bustling world of life sciences, where precision is paramount, a Boston-based startup named LogicFlo is making waves. With a recent seed funding of $2.7 million led by Lightspeed, LogicFlo is set to transform how pharmaceutical, biot... |
| 30.06.2025 | The AI Revolution in Pharmacovigilance: Rethinking Workflows for a Safer Future | Artificial intelligence (AI) is reshaping the landscape of pharmacovigilance. It’s not just a trend; it’s a tidal wave. The pharmaceutical industry is diving deep into AI, with many organizations allocating substantial budgets to harness it... |
| 30.06.2025 | LogicFlo raises $2.7M to bring agentic AI to change work for pharmacology and medtech teams
Join theCUBE Alumni Trust Network
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Boston-based startup LogicFlo AI, an artificial intelligence platform building purpose-built agents for life sciences, today announced it has raised $2.7 million in seed funding led by Lightspeed to scale up its agentic AI service for the p... |
| 30.06.2025 | LogicFlo AI Secures $2.7M to Optimize Life Sciences with AI Agent Workforce | What You Should Know:
– LogicFlo AI, a pioneering Boston-based startup, today announced it has secured $2.7M in seed funding led by Lightspeed with participation from healthcare and enterprise AI investors.
– The investment will accelerate ... |
| 30.06.2025 | AMAMA and LogicFlo AI Raise Early-Stage Funding for Growth The below brands have announced their latest investment rounds. |
Jewellery Brand AMAMA Raises USD 1 Mn from Mistry Ventures
New Delhi-based designer jewellery brand AMAMA has raised USD 1 million in funding from Mistry Ventures LLP, marking its second investment round. The company was earlier backed by ... |
| 25.06.2025 | AI in Pharmacovigilance: Why True Transformation Starts with Workflow Re-Engineering | Daunielle Chipman, Senior Director at IQVIA
There is no doubt that the introduction of artificial intelligence into the field of pharmacovigilance is making waves. According to a 2025 McKinsey survey of leaders in the pharma and MedTech ind... |
| 03.06.2025 | 2Morrow Awarded DiMe Seal, Recognized for Excellence in Digital Behavior Change | At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition challenges all of us to keep raising the bar.”
— Jo Masterson, CEO of 2MorrowKIRKLAND, WA, UNITED STATE... |
| 17.04.2025 | Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer | Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth
LAKEWOOD, Colo., April 17, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Ter... |
| 04.04.2025 | Simplifying Clinical Trials: Addressing Technology Challenges for Site Teams | Rajneesh Patil Vice President, Digital Innovation at IQVIA Nicholas Whitney, Senior Director, Site Suite, IQVIA Technologies
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-... |
| 02.04.2025 | Rural America Loses Independent Physicians and Practices at Alarming Rate, Report Finds | Source: Image by freepik
What You Should Know:
– A new report commissioned by the Physicians Advocacy Institute (PAI) and conducted by Avalere reveals a significant decline in the number of independent physicians and medical practices in ru... |
| 19.03.2025 | Achieving Optimal Clinical Trial Performance with Strategic Site Collaboration, Upcoming Webinar Hosted by Xtalks | www.iqvia.com
In this free webinar, a panel of industry experts will examine the pressing recruitment challenges in clinical research and discuss how strategic site collaboration is essential to overcoming these hurdles. The session will ex... |
| 11.03.2025 | Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults | New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV) on at-risk older adults aged 60 years or over in select high-income APEC countries and regions, including Austral... |
| 02.03.2025 | The Rise of AI in Healthcare: Transforming Insights and Pharmacy Services | Artificial Intelligence (AI) is no longer a futuristic concept. It’s here, reshaping industries and redefining roles. In healthcare, AI is a game-changer. It’s like a lighthouse guiding ships through foggy waters. Two recent developments hi... |
| 28.02.2025 | Belgian startup Salvus Health raises €500K to enhance pharmacy services | Belgian platform for pharmacists Salvus Health has raised €500,000 to improve patient services. With its smart service platform, Salvus Health helps pharmacists streamline their operations and better assist their patients
Belgian startup Sa... |
| 24.02.2025 | IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence | IQVIA a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences and healthcare industries, today announced that IQVIA AI Assistant has been awarded a 2024 PM360 Innovation Awar... |
| 19.02.2025 | Bridging Minds: Singapore's Bold Step into Mental Health Innovation | In a world where mental health often lingers in the shadows, Singapore has stepped into the light. The launch of the Mental Health Innovation Asia Hub (MHIN Asia Hub) marks a pivotal moment in the region's approach to mental health care. Th... |
| 19.02.2025 | The Future of Surgical Safety: How AI is Reshaping Healthcare | In the realm of healthcare, the stakes are high. Patient safety is paramount. Yet, wrong-site surgeries (WSS) remain a haunting specter. These "Never Events" should never happen, yet they do. The World Health Organization (WHO) re... |
| 17.02.2025 | Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide | RIGA, Latvia, Feb. 17, 2025 /PRNewswire/ -- The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets. This year, for the first time, Grindeks products will be de... |
| 24.01.2025 | Navigating the Future of Clinical Trials and Medical Information: The Role of Innovation and AI | The landscape of clinical trials and medical information is shifting. New challenges emerge as the biopharmaceutical industry seeks to expand its horizons. The demand for effective clinical trials is growing, but so are the complexities inv... |
| 22.01.2025 | Unlocking New Horizons: FSP Outsourcing 'Country in a Box' for Clinical Trials | www.iqvia.com
In this free webinar, two industry subject matter experts discuss the patient-access challenges facing the biopharmaceutical industry and how these challenges are driving the need to look beyond the traditional "core coun... |
| 21.01.2025 | Beyond Chatbots: How AI is Reshaping Medical Information Delivery | Simon Johns, Director, Medical Information and Marketed Product Safety at IQVIA
The demand for accurate and timely medical information has never been greater. As healthcare providers and patients navigate an increasingly complex landscape o... |
| 15.01.2025 | The AI Revolution in Healthcare and Data Management: A New Era of Collaboration | The world is on the brink of an AI revolution. Two major players, IQVIA and NVIDIA, are leading the charge in healthcare, while Informatica and Databricks are reshaping data management. These collaborations are not just partnerships; they a... |
| 14.01.2025 | Verastem Oncology: $150 Million Credit Facility Deal Signed | Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced a new credit facility for up to $150 million and an equity investment of $7.5 million with Ober... |
| 13.01.2025 | IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions | IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences.
The... |
| 20.12.2024 | The Rise of Innovative Biotech and Data Analytics in Healthcare | In the ever-evolving landscape of healthcare, two companies stand out: Indapta Therapeutics and PBR Life Sciences. Both are pushing boundaries, but in different arenas. Indapta is diving deep into the world of cancer and autoimmune treatmen... |
| 20.12.2024 | Techstars-backed PBR Life Sciences raises $1 million pre-seed funding | PBR Life Sciences, a Techstars-backed healthcare data analytics company, has raised $1 million in pre-seed funding. The company will use part of the funds to invest in AI infrastructure and expand into Ghana and Kenya.
The funding was raise... |
| 12.12.2024 | Ireland's AI Revolution: A €148 Billion Opportunity by 2038 | Ireland stands on the brink of an AI revolution. A recent report from Accenture reveals that artificial intelligence could contribute a staggering €148 billion to the nation’s GDP by 2038. This figure is not just a number; it represents a s... |
| 10.12.2024 | Beghou Consulting Adds Three Partners to Strengthen Data and Analytics Excellence and Commercialization Expertise Across Emerging Life Sciences Sectors | Yair Markovits, Vishal Singal and Nicole Ventrone have joined Beghou Consulting as Partners, adding collective expertise and data excellence strength across emerging areas of client need.
EVANSTON, Ill., Dec. 10, 2024 /PRNewswire-PRWeb/ -- ... |
| 13.11.2024 | Navigating the Future of Healthcare: Praia Health and ICF's Strategic Moves | In the ever-evolving landscape of healthcare, two companies are making waves. Praia Health and ICF are reshaping how patients interact with health systems and how companies strategize growth. Their recent moves signal a shift towards more p... |
| 08.11.2024 | ICF hires former Labcorp exec to lead corporate development | ICF has hired a new vice president of corporate development in Dr. Eric Hakimov, who will help lead the company’s acquisition efforts and integration processes after the purchases close.
The company said Monday that Hakimov will work with o... |
| 04.11.2024 | Executing Patient Technology Strategies to Meet Unique Clinical Trial Needs, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, learn how to design and execute a patient technology strategy that fits a clinical trial's unique needs. Attendees will gain insights into how to reduce... |
| 25.10.2024 | Globality: AI-Based Sourcing And Procurement Company Raises $47 Million | Globality, a market leader in AI-based sourcing and procurement, announced that it raised $47 million in a Series D-1 and Series D-2 preferred stock offering. This offering was supported by the company’s existing preferred shareholders and ... |
| 23.10.2024 | Globality and Ascent Solutions: Two Titans in Tech Funding and Leadership | In the ever-evolving landscape of technology, two companies have recently made headlines for their strategic moves. Globality, a pioneer in AI-driven sourcing and procurement, has secured a hefty $47 million in funding. Meanwhile, Ascent So... |
| 23.10.2024 | The Rise of AI-Driven Solutions: Globality's $47M Funding and Apple's Vision for the Future | In the bustling world of technology, two stories emerge that highlight the transformative power of artificial intelligence (AI) and the relentless pursuit of innovation. Globality, a company based in Palo Alto, California, has recently secu... |
| 22.10.2024 | Globality Raises $47M in Series D-1 and Series D-2 | Globality, a Palo Alto, CA-based company which specializes in AI-driven sourcing and procurement, raised $47M in Series D-1 and Series D-2 funding.
Backers included Rollins Capital, bringing the total capital raised to $356M.
The company in... |
| 11.10.2024 | IQIVIA Launches GenAI Assistant for Life Sciences | What You Should Know:
– IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a genera... |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 02.10.2024 | Transforming Clinical Data Management with Clinical Data and Analytics Platforms, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, gain insights into current business challenges that sponsors face in clinical data management and the impact of these challenges on trial timelines, reg... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors --
BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 11.09.2024 | IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance with Its AI Solutions | IQVIA's AI solutions streamline workflows, drive automation to connect process improvements, and provide insights into individual activities, improving patient safety and commercial performance.
SAN ANTONIO, Sept. 11, 2024 /PRNewswire/ -- F... |
| 10.09.2024 | Amid Record Growth and Adoption of Judi Clinical Trial Collaboration Platform, AG Mednet Announces New Key Leadership Appointments | BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid growth and momentum, driven by the widespread adoption of its Judi platform on over 2,000 clinical tr... |
